Home » EUROPEAN PANEL BACKS SAFETY OF ROCHE'S TAMIFLU
EUROPEAN PANEL BACKS SAFETY OF ROCHE'S TAMIFLU
The European Medicines Agency said on Thursday it was recommending no changes in the safety information for Roche's flu drug Tamiflu, following a review of possible links with psychiatric disorders. The Committee for Medicinal Products for Human Use also recommended extending the use of Tamiflu to include prevention of influenza in children between 1 and 13 years.
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May